Sign In
Buy ADCT
$1.15
+0.0600 (+5.50%)
At Close: Jun 23, 2026
AMC Entertainment, Pharvaris And Some Other Big Stocks Moving Lower On Monday
03:19pm, Monday, 22'nd Aug 2022 Benzinga
AMC Entertainment Holdings, Inc. (NYSE: AMC) fell 37.1% to $11.34 as the company's APE preferred shares begin trading on the New York Stock Exchange. The preferred shares were issued to all common st
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
07:43am, Monday, 15'th Aug 2022 Benzinga
Gainers
Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Twin Vee Powercats Co. (NASDAQ: VEEE) shares cl
ADC Therapeutics SA (ADCT) Q2 2022 Earnings Call Transcript
04:01am, Wednesday, 10'th Aug 2022 The Motley Fool
ADCT earnings call for the period ending June 30, 2022.
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
12:25pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
ADC Therapeutics SA (ADCT) delivered earnings and revenue surprises of 23.96% and 14.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
09:47am, Tuesday, 09'th Aug 2022
ADC Therapeutics SA (ADCT) delivered earnings and revenue surprises of 23.96% and 14.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Beats Revenue Estimates (Revised)
08:27am, Friday, 05'th Aug 2022 Zacks Investment Research
Intercept (ICPT) delivered earnings and revenue surprises of -28.30% and +5.86%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Misses Revenue Estimates
12:25pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Intercept (ICPT) delivered earnings and revenue surprises of -28.30% and 24.34%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Perrigo (PRGO) to Report Q2 Earnings: What's in the Cards?
03:58pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Perrigo's (PRGO) new products and products added through acquisitions are expected to have aided the company's top line in the soon-to-be-reported quarter.
ADC Therapeutics to Host Second Quarter 2022 Financial Results Conference Call on August 9, 2022
07:15am, Tuesday, 02'nd Aug 2022
LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT) today announced that it will host a conference call and live webcast on Tuesday, August 9, 2022 at 8:30 a.m. ET to report finan
Moderna (MRNA) to Report Q2 Earnings: What's in the Cards?
03:40pm, Monday, 01'st Aug 2022 Zacks Investment Research
Investor focus is likely to be on the progress of Moderna's (MRNA) late-stage pipeline candidates on the second-quarter earnings call that can lower its dependence on Spikevax.
Vertex (VRTX) to Report Q2 Earnings: What's in the Cards?
07:51pm, Friday, 29'th Jul 2022 Zacks Investment Research
On Vertex Pharmaceuticals' (VRTX) Q2 earnings call, investors are most likely to focus on the sales performance of its cystic fibrosis (CF) medicines and updates on its non-CF pipeline candidates.
Earnings Preview: Moderna (MRNA) Q2 Earnings Expected to Decline
02:02pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ADC Therapeutics SA (ADCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
02:01pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
ADC Therapeutics SA (ADCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Centene (CNC) Gears Up for Q2 Earnings: What Lies Ahead?
04:24pm, Monday, 25'th Jul 2022 Zacks Investment Research
Centene's (CNC) second-quarter results are likely to reflect growth in premiums.
Teladoc Health (TDOC) Gears Up for Q2 Earnings: What Lies Ahead?
04:23pm, Monday, 25'th Jul 2022 Zacks Investment Research
Teladoc Health's (TDOC) second-quarter results are likely to reflect growth in Subscription Access Fees.
